In a study, a team of Korean researchers developed an AI model using OCT images to predict neovascular AMD treatment outcomes after anti-VEGF injections. The model highlights AI’s potential in ...
Intravitreal injections of anti-VEGF agents have become an important tool in the management of some of the most common retinal and choroidal neovascular diseases. Adverse effects are uncommon ...
Despite the severe vision loss often experienced by people with wet AMD, less than half of patients treated with monthly eye injections of anti-VEGF therapies show any major vision improvements.
which can damage the eye. Anti-VEGF medications block the production of the protein and can improve vision. However, they currently need to be administered via an intravitreal injection ...
LUNA Phase 2 Trial and OPTIC First-in-Human Trial - Background and Baseline Prior Anti-VEGF Injections LUNA is an ongoing double-masked, randomized Phase 2 trial. 60 patients with wet AMD were ...
Despite the severe vision loss often experienced by people with wet AMD, less than half of patients treated with monthly eye injections, known as anti-VEGF therapies, show any major vision ...
Treatments such as laser therapy target leaking blood vessels or abnormal growth, while anti-VEGF injections block new vessels from forming and leaking, and steroid injections can be used to reduce ...